Streetbeat News

Revenues

SEIC

SEI Investments (NASDAQ:SEIC) has received mixed analyst ratings in the last three months, with 3 somewhat bullish and 1 indifferent rating. The average 12-month price target has been raised to $75.5, indicating a positive outlook. SEI Investments, a provider of investment services, has shown solid revenue growth and strong financial performance, despite a market capitalization below industry benchmarks and a net margin lagging behind industry averages.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 3:01 pm

KKR

KKR & Co Inc (NYSE:KKR) is analyzed against competitors in the Capital Markets industry, highlighting its financial metrics, market position, and growth prospects. KKR's PE and PB ratios suggest potential undervaluation, while its PS ratio indicates a rich valuation based on revenue. The company outperforms industry peers in ROE, EBITDA, gross profit, and revenue growth, demonstrating strong operational performance and growth potential.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 3:00 pm

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) has received mixed analyst ratings over the last three months, with a shift towards more bullish sentiment. The average 12-month price target is $153.78, marking an 8.39% increase from the previous target. Analyst actions include both upgrades and downgrades, reflecting responses to market conditions and company performance. Neurocrine Biosciences, a pharmaceutical company, has shown a solid revenue growth rate of 25.05% as of December 31, 2023, but faces challenges in profitability and efficiency metrics compared to industry averages.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 3:00 pm

HCAT

Health Catalyst (NASDAQ:HCAT) has received mixed analyst ratings over the past three months, with 7 analysts offering views that range from bullish to somewhat bullish, with no indifferent, somewhat bearish, or bearish ratings. The 12-month price targets show an average of $13.14, with a high of $16.00 and a low of $10.00, indicating a slight increase from the previous average target of $13.00. The company's financial performance shows positive revenue growth and a strong net margin, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 3:00 pm

PCLOF

PharmaCielo Ltd. (OTCQX:PCLOF) announced its intention to acquire Siam Ventures Corporation, aiming to expand its cannabis operations into Thailand amidst regulatory changes. The deal involves issuing PharmaCielo shares worth CA$3 million ($2.2 million) to Siam Ventures' shareholders. This acquisition is seen as a strategic move to access large Asian markets as they open to cannabinoids. Concurrently, PharmaCielo is undertaking a non-brokered private placement of units to raise CA$2 million, potentially increasing to CA$3 million, to support its expansion and operational needs.

Portfolio Pulse from Jelena Martinovic

April 10, 2024 | 2:49 pm

BMY

JNJ

MRK

MYNZ

PFE

Pharmaceutical giants Bristol Myers Squibb, Merck, Pfizer, and Johnson & Johnson are navigating patent cliffs by focusing on cancer and heart disease treatments. Johnson & Johnson acquired Shockwave Medical to enhance its heart disease treatments, while Pfizer invested in cancer specialist Seagen. Bristol Myers Squibb reported positive trial data for a subcutaneous version of Opdivo, and Merck announced successful trials in cancer treatments with Moderna. Mainz Biomed reported significant progress in cancer detection.

Portfolio Pulse from Upwallstreet

April 10, 2024 | 2:47 pm

ENPH

Enphase Energy Inc (NASDAQ:ENPH) shares dropped 7.2% to $113.20 amid overall market weakness due to hotter-than-expected March inflation data, with the CPI rising to 3.5%. This inflation increase, marking the second consecutive month of growth, could lead to higher input costs and reduced demand for Enphase Energy's renewable energy solutions.

Portfolio Pulse from Henry Khederian

April 10, 2024 | 2:24 pm

DAL

During a conference call, a Delta Air Lines executive mentioned that in Latin America, unit revenues are expected to decline by double digits due to pressure in short-haul leisure markets. However, there is an expectation of healthy improvements in these markets in the second half of the year as supply and demand come back into balance.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 2:21 pm

DAL

During a conference call, a Delta Air Lines executive stated that pilot hiring has stabilized, allowing for an increase in the capacity expected to be flown over the summer.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 2:18 pm

DAL

During a conference call, a Delta Air Lines executive mentioned that, similar to the first quarter, the second quarter is expected to face challenges due to the normalization of travel credits.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 2:18 pm